Youhei Fujioka
Yonago, 6838504, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Erratum for Ikeda et al., "Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease".
Journal: Yonago acta medica
Published: November 30, 2020
Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease.
Journal: Yonago acta medica
Published: July 17, 2020
Coenzyme Q10 suppresses apoptosis of mouse pancreatic β-cell line MIN6.
Journal: Diabetology & metabolic syndrome
Published: April 12, 2018
Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity.
Journal: Journal of diabetes investigation
Published: February 12, 2017
Low serum galectin-3 concentrations are associated with insulin resistance in patients with type 2 diabetes mellitus.
Journal: Diabetology & metabolic syndrome
Published: July 12, 2014
Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: April 03, 2014
The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical study.
Journal: BMC research notes
Published: July 03, 2013
20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.
Journal: Cardiovascular diabetology
Published: December 31, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026